CD177 and neoplasm: 75 This was possibly achieved due to nanorods directly targeting membranes of tumour cells via in situ dithiocarbamates formation as a result of robust attachment of ligands with high affinity for overexpressed cell-surface receptors.75 This demonstrates how dithiocarbamate moiety in the targeted drug delivery is important for tumours specificity.